UCSFi001-A-1N

iN-SRCAP-R2444-5

The cell line is not validated yet.

General

Cell Line

hPSCreg name UCSFi001-A-1N
Cite as:
UCSFi001-A-1N
Alternative name(s)
iN-SRCAP-R2444-5
Cell line type Human induced pluripotent stem cell (hiPSC)
Similar lines No similar lines found.
Last update 14th October 2025
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator Murdoch Children's Research Institute (MCRI)

External Databases

BioSamples SAMEA120324912

General Information

* Is the cell line readily obtainable for third parties?
No
Subclone of

Donor Information

General Donor Information

Sex male
Ethnicity Asian

Phenotype and Disease related information (Donor)

Diseases No disease was diagnosed.
Family history N/A
Is the medical history available upon request? No
Is clinical information available? Limited clinical information - EKG

Other Genotyping (Donor)

Is there genome-wide genotyping or functional data available?
No

Donor Relations

Other cell lines of this donor

External Databases (Donor)

BioSamples SAMEA5843920

Ethics

Also have a look at the ethics information for the parental line UCSFi001-A .
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used?

hIPSC Derivation

General

The source cell information can be found in the parental cell line UCSFi001-A.

Reprogramming method

Vector type Non-integrating
Vector Episomal
Genes
Is reprogramming vector detectable?
No
Methods used
PCR

Vector free reprogramming

Other

Derived under xeno-free conditions
Unknown
Derived under GMP?
Unknown
Available as clinical grade?
Unknown

Culture Conditions

Surface coating Vitronectin
Feeder cells
No
Medium Other medium:
Base medium: StemFlex™
Main protein source:
Serum concentration: %
Has Rock inhibitor (Y27632) been used at cryo previously with this cell line?
No
Has Rock inhibitor (Y27632) been used at thaw previously with this cell line?
Yes

Characterisation

Analysis of Undifferentiated Cells
Marker Expressed Immunostaining RT-PCR Flow Cytometry Enzymatic Assay Expression Profiles
POU5F1 (OCT-4)
Yes
TRA 1-60
Yes
TRA 1-81
Yes
SSEA-4
Yes
NANOG
Yes
Morphology pictures
Differentiation Potency
Endoderm
Ont Id: UBERON_0000925
In vitro spontaneous differentiation
Marker Expressed
SOX17
Yes
Morphology
Mesoderm
Ont Id: UBERON_0000926
In vitro spontaneous differentiation
Marker Expressed
Smooth Muscle Actin
Yes
Morphology
Ectoderm
Ont Id: UBERON_0000924
In vitro spontaneous differentiation
Marker Expressed
MAP2
Yes
Morphology

Microbiology / Virus Screening

Mycoplasma Negative

Genotyping

Karyotyping (Cell Line)

Has the cell line karyotype been analysed?
Yes
46,XY

Other Genotyping (Cell Line)

Genetic Modification

Disease/phenotype related modifications
Synonyms
  • floating-Harbor syndrome
  • FHS
  • FLHS
  • Pelletier-Leisti syndrome
  • floating-HARBOR syndrome
  • short stature with delayed bone age, expressive language delay, a triangular face with a prominent nose and deep-set eyes
  • Floating Harbor Syndrome
show more synonyms
Genetic modifications
Variant
16p11.2
c.7330C>T
p.Arg2444*
Heterozygous
Genetic modifications not related to a disease
Neurogenin 2 (target)
Transgene expression
19q13; AAVS1
The line carries a tetracycline-inducible Ngn2 expression cassette that enables rapid differentiation into cortical neurons upon the addition of doxycycline to the culture.